Navigation Links
Genta Incorporated to Present Multiple Abstracts at the Annual,Meeting of the American Society of Clinical Oncology

ts and proprietary rights; -- the impact of litigation that has been brought against the Company and its officers and directors and any proposed settlement of such litigation; -- the Company's ability to regain compliance with the NASDAQ's listing qualifications, or its ability to successfully appeal the NASDAQ delisting; and -- the other risks described under Certain Risks and Uncertainties Related to the Company's Business, as contained in the Company's Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a number of factors that could cause actual results and developments to differ materially. For a discussion of those risks and uncertainties, please see the Company's Annual Report on Form 10-K for 2006 and its most recent quarterly report on Form 10-Q.

    CONTACT:

    Tara Spiess/Andrea Romstad

    TS Communications Group, LLC

    (908) 286-3980

    

info@genta.com

CONTACT: Tara Spiess or Andrea Romstad of TS Communications Group, LLC,+1-908-286-3980, or , for Genta Incorporated info@genta.com

Web site: http://www.genta.com/

Ticker Symbol: (NASDAQ-NMS:GNTA)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
Post Your Comments:
(Date:3/4/2015)... 2015 Research and Markets ( ... "Negative Pressure Wound Therapy Market (Conventional and ... Size, Share, Growth, Trends and Forecast 2014 - ... The global negative pressure wound therapy ... geography. By product types the NPWT market is ...
(Date:3/4/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... 27 th Annual ROTH Conference, taking place March ...  Dr. Michael Berelowitz , Chairman of the ... overview on March 10, 2015.   ...
(Date:3/4/2015)... March 4, 2015  KemPharm, Inc., a clinical-stage ... development of proprietary new molecular entity (NME) prodrugs, ... Woody as Chief Commercial Officer.  Ms. Woody ... commercial experience building businesses for both emerging and ... As Chief Commercial Officer, Ms. Woody ...
Breaking Medicine Technology:Global Negative Pressure Wound Therapy (Conventional and Single Use NPWT Systems) Market Report 2014-2020 2Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3KemPharm, Inc. Appoints Tracy M. Woody as Chief Commercial Officer 2
... , , PALO ALTO, Calif. ... biotechnology company, today announced the appointment of Mark W. ... position, Mr. Davis will lead TOPICA,s clinical development activities for ... (nail and nail bed fungal infections) and tinea pedis (athlete,s ...
... , HOUSTON , Feb. 17   , , , ... IN THE DISTRICT COURT OF, ... , ... , ...
Cached Medicine Technology:TOPICA Names Mark W. Davis Vice President of Clinical Development 2TOPICA Names Mark W. Davis Vice President of Clinical Development 3Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 2Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 3Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 4Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 5Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 6Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 7Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 8Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 9
(Date:3/4/2015)... Nitrosigine®, a patented complex of bonded arginine silicate ... is hosting the Nitrosigine Pump Challenge at the America’s ... The Arnold Sports Festival in Columbus, Ohio. The event ... 2015. , Nitrosigine is a patented ingredient of ... status; now affirmed as GRAS.^ It has been clinically ...
(Date:3/4/2015)... 2015 Brassica Protection Products LLC, an ... rebrand of its SGS™ brand of glucoraphanin to truebroc™. ... glucoraphanin, which is the most concentrated source of glucoraphanin ... includes a new truebroc logo and refreshed website and ... brand name. , “We are thrilled to unveil ...
(Date:3/4/2015)... 04, 2015 Ada Products Company, ... on Wednesday its strategic partnership with the Dental Exchange ... that will introduce them to engaging, inspiring ideas, products, ... , The Dental Exchange is a first-of-its ... dental industry. Unlike other social platforms, the Dental Exchange ...
(Date:3/4/2015)... TheraBreath is proud to announce a new probiotic lozenge ... with overall health. , Many health experts agree that ... bad bacteria that can cause unwanted infections. While most people ... will need the help of a probiotic to elevate the ... Packed with the S. salivarius M18 & K12 strains of ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... a worrisome public health issue worldwide. The rising prevalence ... economic and social burden in both developed and developing ... is projected to rise to 1.5 billion, equating to ... of these patients are forecast to come from the ...
Breaking Medicine News(10 mins):Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3Health News:Brassica Protection Products Rebrands its SGS™ Brand of Glucoraphanin to truebroc™ 2Health News:Ada Products Company, Inc. Announces Strategic Partnership with the Dental Exchange 2Health News:TheraBreath introduces a new line of probiotic lozenges that strengthen the body’s ability to fight germs 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 4
... TOWN, W.Va., Feb. 5 ReBuilder Medical Technologies, Inc. ... based treatments for diabetic peripheral neuropathy and ... an increase in sales for the month of January. ... we appear to be recession proof and this monthly ...
... Data will mark 1st official measure of unemployment rate ... The U.S. Department of Labor will, for the first ... disabilities on Friday, Feb. 6. This information will ... conditions affect Americans with disabilities. Although it is ...
... 2009 Narcotics have an irreversible effect on the ... to Dr. Stphane Potvin of the Universit de Montral ... Hospital. , According to his research, some 33 ... drug addiction. The study has shown that drug consumption ...
... the nation,s mayors, U.S. Conference of Mayors President Miami ... the new Congress for taking a bold step towards ... With the signing into law of the Children,s ... extends government health benefits to an additional four million ...
... U.S. Conference of Catholic Bishops (USCCB) has launched ... widely-supported pro-life policies and to oppose the federal ... 24-25, the campaign is being coordinated through the ... Human Life Amendment (NCHLA).To date, tens of millions ...
... the Obama Administration,s call for change comes new momentum ... encompass universal coverage along with evidence-based methods of prevention, ... editorial in the January 2009 issue (Volume 15, Number ... and Complementary Medicine, a peer-reviewed journal published by ...
Cached Medicine News:Health News:ReBuilder Medical Technologies, Inc. (RBRM) Announces Sales Increase In Jan. 09 2Health News:U.S. Labor Department to begin new monthly data series on people with disabilities from Current Population Survey on Feb. 6 2Health News:Massive Nationwide Pro-Life Postcard Campaign Underway 2Health News:Alternative and Complementary Medicine Should Have Role in New Era of Health Care Reform 2
... second-generation application software for use with the ... release includes a range of new features ... Included are automatic tools to aid diagnosis ... which highlights images that may include blood ...
... (EGG) Analysis for POLYGRAM NET™ works with ... and analyze multichannel EGG signals. The EGG ... preparation by performing an automatic electrode impedance ... the beginning of a recording. If the ...
... Bile Reflux Analysis for POLYGRAM NET® is an ... add-on allows medical professionals to upload and analyze ... reflux recorder. The primary difference is that bile ... a certain wavelength of light corresponding to the ...
Symbia T6, a True Point SPECT·CT system, combines a dual-detector variable angle gamma camera with a six slice CT scanner for advanced oncology, neurology, and cardiology applications....
Medicine Products: